Medication-info.com Search Menu

Succinylcholine (Anectine): Uses, Side Effects and Dosage

Status:
Prescription (Rx) Boxed warning Being discontinued since July 23, 2026 Facts
Strength:
20 mg/mL
Brand names:
Active ingredient:

Patient information: uses, side effects, how to take - Succinylcholine

INSTRUCTIONS FOR USE

CAUTION: Assure that the needle or Needleless Luer Access Device (NLAD) is securely attached before beginning the injection. Visually inspect the syringe-needle or syringe-NLAD connection before and during drug administration.

Figure 1: Outer Packaging and Prefilled Syringe

Succinylcholine Chloride Injection may be administered intravenously or intramuscularly.

Inspect the outer packaging (flow wrap) and the syringe label by verifying:

Plastic overwrap integrity

Drug name

Drug strength

Fill volume

Route of administration

Expiration date to be sure that the drug has not expired

Sterile field applicability

Do not use if package has been damaged

Open the outer packaging and remove the syringe from the outer packaging. Do not pop syringe through. (See Figure 2)

Figure 2

Perform visual inspection on the syringe by verifying:

Absence of syringe damage

Absence of external particles

Absence of internal particles

Proper drug color

Push plunger rod slightly while tip cap is still on to break the stopper loose.

Remove the tip cap by twisting it off (Figure 3).

Discard the tip cap.

Expel air bubble(s).

Connect the syringe to an appropriate injection connection depending on the route of administration.

Before injection, ensure that the syringe is securely attached to the needle or NLAD.

Depress plunger rod to deliver the required dose of medication. Ensure that pressure is maintained on the plunger rod during the entire administration. Waste residual medication per institutional policy.

Remove syringe from NLAD (if applicable) and discard into appropriate receptacle. When needle is connected to the syringe, to prevent needle-stick injuries, do not recap needles.

NOTES:

All steps must be performed sequentially.

Do not autoclave syringe.

Do not use this product on a sterile field.

Do not introduce any other fluid into the syringe at any time.

Do not dilute for IV push.

This product is for single dose only, discard unused portion.

For more information concerning this drug, please call Fresenius Kabi USA, LLC at 1-800-551-7176.

To report SUSPECTED ADVERSE REACTIONS, contact Fresenius Kabi USA, LLC at 1-800-551-7176 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

About this document

Source: FDA drug labeling via NLM DailyMed · Application number: ANDA 217884 · View the label on DailyMed

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Succinylcholine

Rx or OTC
Prescription (Rx)?
  • This drug is available only with a prescription from a licensed healthcare provider.
  • Rx
Boxed warning Yes – this drug has a boxed warning (also called a black box warning), the strongest warning of the FDA.
Drug class Depolarizing Neuromuscular Blocker
Active ingredient Succinylcholine chloride dihydrate 20 mg/mL
Dosage form Injection, solution
Route Intramuscular, Intravenous
Marketing status listed in the FDA NDC Directory
Company (applicant) FRESENIUS KABI USA
FDA approval ANDA 217884Abbreviated New Drug Application (ANDA) – generic drug Approved February 11, 2025
Therapeutic equivalence (TE) code APCodes starting with A mean the FDA rates the drug therapeutically equivalent to its reference drug (Orange Book).
Generics Quelicin with the same TE code
Manufacturers 23 labelers list this drug on DailyMed
Drug shortage
  • Being discontinued since July 23, 2026
Recalls
  • September 26, 2025: Class II recall: Out-of-Specification (OOS) result during the 6-month stability testing; decreased preservative concentration.
  • August 27, 2025: Class II recall: Failed Impurities/Degradation Specifications: Out-of-Specification test results obtained for any individual unknown degradation impurity.
Packages (NDC)
Package
20 mg/mL – 5 ml in 1 syringe, plastic / 10 in 1 carton NDC 65219-274-01

Source: FDA drug labeling via NLM DailyMed, data as of October 31, 2026. FDA data (DailyMed, Orange Book, Drug Shortages, enforcement reports). Not a substitute for the advice of a doctor or pharmacist.